Sunlenca 300 mg film-coated tablets

Company:
Gilead Sciences Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Lenacapavir
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/22/1671/001

300mg

J05AX31

Film-coated tablet